149506-79-6 Usage
Description
4-(dibenzylamino)cyclohexanone is a chemical compound with a molecular weight of 359.484 g/mol and is identified by its CAS number 2973-78-8. It is structurally characterized by an amine group attached to a cyclohexanone ring, which is further substituted by benzyl groups. 4-(dibenzylamino)cyclohexanone belongs to the class of compounds known as Benzene and substituted derivatives.
Uses
As of now, there isn't much information available regarding the specific applications of 4-(dibenzylamino)cyclohexanone. However, given its structural features, it may potentially be used in various industries such as pharmaceuticals, materials science, or chemical research. The following are hypothetical uses based on its chemical structure:
Used in Pharmaceutical Industry:
4-(dibenzylamino)cyclohexanone could be used as an intermediate compound for the synthesis of pharmaceutical drugs, given its amine and cyclohexanone functional groups, which are common in many drug molecules.
Used in Materials Science:
4-(dibenzylamino)cyclohexanone might be employed as a building block for the development of new materials with specific properties, such as improved thermal stability or enhanced solubility in certain solvents.
Used in Chemical Research:
4-(dibenzylamino)cyclohexanone could be utilized in academic or industrial research settings to study its physical and chemical properties, such as melting point, boiling point, solubility, and stability, as well as its potential reactivity with other compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 149506-79-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,5,0 and 6 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 149506-79:
(8*1)+(7*4)+(6*9)+(5*5)+(4*0)+(3*6)+(2*7)+(1*9)=156
156 % 10 = 6
So 149506-79-6 is a valid CAS Registry Number.
149506-79-6Relevant articles and documents
CYCLIN-DEPENDENT KINASE INHIBITING COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS
-
, (2021/11/26)
This invention is in the area of cell cycle inhibiting compounds for the treatment of disorders involving abnormal cellular proliferation, and include selective CDK2 inhibitors for medical therapy and their pharmaceutically acceptable salts and compositions.
TREATMENT OF CDK4/6 INHIBITOR RESISTANT NEOPLASTIC DISORDERS
-
, (2020/10/19)
This invention is to methods for treating disorders involving abnormal cellular proliferation that have developed resistance to a selective CDK4/6 inhibitor.
HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ABNORMAL CELLULAR PROLIFERATION
-
, (2019/07/20)
This invention is in the area of heterocyclic-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.
